CURRICULUM VITAE EDUCATION AND TRAINING



Similar documents
These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

Historical Basis for Concern

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Guidelines for Management of Renal Cancer

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.

Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.

Kidney Cancer OVERVIEW

Implementation Date: April 2015 Clinical Operations

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer

Prostate Cancer. Treatments as unique as you are

Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma

Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery

PSA Screening for Prostate Cancer Information for Care Providers

DIAGNOSIS OF PROSTATE CANCER

Does my patient need more therapy after prostate cancer surgery?

7. Prostate cancer in PSA relapse

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward

2016 Mayo Clinic Urology Review

Us TOO University Presents: Understanding Diagnostic Testing

Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD

SMALL CELL LUNG CANCER

Name (Youngsook Son) Education Major Activities

Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)

Clinical Management Guideline Management of locally advanced or recurrent Renal cell carcinoma. Protocol for Planning and Treatment

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

Prostate Cancer Treatment: What s Best for You?

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

Precise, Minimally Invasive Prostate Cancer Removal

Understanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding

Medullary Renal Cell Carcinoma Case Report

Clinical Practice Assessment Robotic surgery

NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)

Thomas A. Kollmorgen, M.D. Oregon Urology Institute

The 4Kscore blood test for risk of aggressive prostate cancer

An Introduction to PROSTATE CANCER

PSA screening: Controversies and Guidelines

Advances in Diagnostic and Molecular Testing in Prostate Cancer

PROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology

Early Prostate Cancer: Questions and Answers. Key Points

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

How To Treat A Uterine Sarcoma

Lung Cancer Treatment Guidelines

Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery

Prostate Cancer In-Depth

Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka

Prostate Cancer Action Plan: Choosing the treatment that s right for you

PROSTATE CANCER 101 WHAT IS PROSTATE CANCER?

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

Report series: General cancer information

How To Know If You Should Get A Brachytherapy Or Radioactive Seed Implantation

NERVE GRAFT TO RESTORE ERECTILE FUNCTION DURING RADICAL PROSTATECTOMY

Metastatic Prostate Cancer Causing Complete Obstruction of the IVC

Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

HEALTH NEWS PROSTATE CANCER THE PROSTATE

Prostate Cancer Treatment Comparison

Translocation Renal Cell Carcinomas

A912: Kidney, Renal cell carcinoma

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Adjuvant Therapy for Breast Cancer: Questions and Answers

A918: Prostate: adenocarcinoma

Small cell lung cancer

1. What is the prostate-specific antigen (PSA) test?

New Data Supporting Modified RECIST (mrecist) for Hepatocellular Carcinoma. Running Title: Modified RECIST (mrecist) for Hepatocellular Carcinoma

بسم هللا الرحمن الرحيم

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

Radiotherapy in Plasmacytoma and Myeloma. David Cutter Multiple Myeloma NSSG Annual Meeting 14 th September 2015

ANDREW CALLAWAY JAMES, MD

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)

Something Old, Something New.

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer

Stage I, II Non Small Cell Lung Cancer

The TV Series. INFORMATION TELEVISION NETWORK

da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy)

Combined Harvard Urologic Oncology Fellowship Program

CancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany

Brian Louis Cohen, M.D., M.P.H.

Robert Bristow MD PhD FRCPC

Intravesical Therapy for Bladder Cancer

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

Radiation Therapy for Prostate Cancer

THYROID CANCER. I. Introduction

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.

male sexual dysfunction

Lung cancer is not just one disease. There are two main types of lung cancer:

Cancer of the Cardia/GE Junction: Surgical Options

OBJECTIVES By the end of this segment, the community participant will be able to:

POLICY A. INDICATIONS

1400 Telegraph Bloomfield Hills, MI Phone number/ fax Number CANCER TREATMENT

Transcription:

CURRICULUM VITAE NAME CURRENT POSITION ADDRESS Dalsan You Clinical Assistant Professor Department of Urology, Asan Medical Center, University of Ulsan College of Medicine 88, Olympic Ro 43 Gil, Songpa Gu, Seoul, 138 736, KOREA EDUCATION AND TRAINING 1995. 3 2001. 2 Chungnam National University Medicine M.D. (2001) 2004. 3 2008. 2 Graduate School, University of Ulsan Medicine M.S. (2008) 2009. 3 2011. 2 Graduate School, University of Ulsan Medicine Ph.D. (2011) 2001. 3 2002. 2 Asan Medical Center Intern 2002. 3 2006. 2 Asan Medical Center Urology Resident 2009. 5 2011. 2 Asan Medical Center Urology Clinical Fellow PROFESSIONAL EXPERIENCE 2011. 3 2012. 2 Asan Medical Center (Part Time) Clinical Professor SPECIALITY BOARD Korean Board of Urology GCP TRAINING 질병관리본부 [on] 10 RE 0000484 (2011.08.28) 질병관리본부 [on] 13 RE 00003547 (2013.11.21)

PUBLICATIONS SCI(E) 53. Kim T, Ahn JH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Lee JL. Pulmonary Metastasectomy Could Prolong Overall Survival in Select Cases of Metastatic Urinary Tract Cancer. Clin Genitourin Cancer. 2015 May 2. [Epub ahead of print] 52. Kim YR, Lee JL, You D, Jeong IG, Song C, Hong B, Hong JH, Ahn H. Gemcitabine plus split dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin unfit patients with advanced urothelial carcinoma. Cancer Chemother Pharmacol. 2015 May 23. [Epub ahead of print] 51. Kim A, Kwon T, You D, Jeong IG, Go H, Cho YM, Hong JH, Ahn H, Kim CS. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma. J Korean Med Sci. 2015 Apr;30(4):385 9. 50. You D, Jang MJ, Kim BH, Song G, Lee C, Suh N, Jeong IG, Ahn TY, Kim CS. Comparative Study of Autologous Stromal Vascular Fraction and Adipose Derived Stem Cells for Erectile Function Recovery in a Rat Model of Cavernous Nerve Injury. Stem Cells Transl Med. 2015 Apr;4(4):351 8. 49. Kwon T, Jeong IG, Ryu J, Lee C, Lee C, You D, Kim CS. Renal Function is Associated with Nephrometry Score After Partial Nephrectomy: A Study Using Diethylene Triamine Penta Acetic Acid (DTPA) Renal Scanning. Ann Surg Oncol. 2015 Mar 19. [Epub ahead of print] 48. Park I, Lee JL, Ahn JH, Lee DH, Lee KH, You D, Jeong IG, Song C, Hong B, Hong JH, Ahn H. Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR TKI and mtor inhibitor. Cancer Chemother Pharmacol. 2015 May;75(5):1025 35. 47. Han KS, You D, Jeong IG, Kwon T, Hong B, Hong JH, Ahn H, Ahn TY, Kim CS. Is Intravesical Bacillus Calmette Gu?rin Therapy Superior to Chemotherapy for Intermediate risk Non muscle invasive Bladder Cancer?: An Ongoing Debate. J Korean Med Sci. 2015 Mar;30(3):252 8. 46. Lee C, You D, Sohn M, Jeong IG, Song C, Kwon T, Hong B, Hong JH, Ahn H, Kim CS. Prognostic value of ABO blood group in patients with renal cell carcinoma: single institution results from a large cohort. J Cancer Res Clin Oncol. 2015 Feb 17. [Epub ahead of print] 45. Kwon T, Jeong IG, Yoo S, Lee J, Hong S, You D, Hong JH, Ahn H, Kim CS. Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making. Int Urol Nephrol. 2015 Feb 14. [Epub ahead of print] 44. Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS. FDG PET CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy. Ann Surg Oncol. 2015 Jan 30. [Epub ahead of print] 43. Song SH, Jeong IG, You D, Hong JH, Hong B, Song C, Jung WY, Cho YM, Ahn H, Kim CS. VEGF/VEGFR2 and PDGF B/PDGFR β expression in non metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients. Int J Clin Exp Pathol. 2014 Oct 15;7(11):7681 9. 42. Kim CS, Kim Y, Kwon T, Yoon JH, Kim KH, You D, Hong JH, Ahn H, Jeong IG. Regulatory T cells and TGF β1 in clinically localized renal cell carcinoma: Comparison with age matched healthy controls. Urol Oncol. 2014 Dec 10. [Epub ahead of print] 41. Hong S, Kwon T, You D, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS. Incidence of benign results after laparoscopic radical nephroureterectomy. JSLS. 2014 Oct;18(4). 40. Han KS, Song G, Song C, You D, Jeong IG, Hong JH, Ahn H, Kim CS, Hong B. Comparison of Hand assisted Laparoscopic Versus Robot assisted Laparoscopic Versus Open Partial Nephrectomy in Patients with T1 Renal Masse. J Endourol. 2014 Oct 29. [Epub ahead of print] 39. You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Ahn H, Kim CS. Analysis of pre operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era. Jpn J Clin Oncol. 2015 Jan;45(1):96 102. 38. Kwon T, Jeong IG, Lee J, Lee C, You D, Hong B, Hong JH, Ahn H, Kim CS. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse probability of treatment weighting. J Cancer Res Clin Oncol. 2014 Aug 14. [Epub ahead of print] 37. Kwon T, Jeong IG, You D, Han KS, Hong S, Hong B, Hong JH, Ahn H, Kim CS. Obesity and prognosis in muscle invasive bladder cancer: The continuing controversy. Int J Urol. 2014 Nov;21(11):1106 12.

36. Hwang S, Park SK, Lee HY, Kim SW, Lee JS, Choi EK, You D, Kim CS, Suh N. mir 140 5p suppresses BMP2 mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett. 2014 Aug 25;588(17):2957 63. 35. Park SK, Lee JS, Choi EK, You D, Kim CS, Suh N. Global knockdown of micrornas affects the expression of growth factors and cytokines in human adipose derived mesenchymal stem cells. BMB Rep. 2014 Aug;47(8):469 74. 34. Kwon T, Jeong IG, You D, Hong B, Hong JH, Ahn H, Kim CS. Long term oncologic outcomes after radical cystectomy for bladder cancer at a single institution. J Korean Med Sci. 2014 May;29(5):669 75. 33. Kwon T, Lee JL, Kim JK, You D, Jeong IG, Song C, Ahn H, Kim CS, Hong JH. The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapy. J Cancer Res Clin Oncol. 2014 Oct;140(10):1751 8. 32. You D, Song SH, Cho YM, Lee JL, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Predictive role of tissue based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma. World J Urol. 2015 Jan;33(1):111 8. 31. Kwon T, Lee JL, You D, Jeong IG, Song C, Ahn H, Kim CS, Hong JH. Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy. J Surg Oncol. 2014 Aug;110(2):145 50. 30. Kwon T, Jeong IG, Pak S, You D, Song C, Hong JH, Ahn H, Kim CS. Renal tumor size is an independent prognostic factor for overall survival in von Hippel Lindau disease. J Cancer Res Clin Oncol. 2014 Jul;140(7):1171 7. 29. Kwon T, Jeong IG, Park M, You D, Lee J, Kim HK, Hong S, Hong JH, Ahn H, Kim CS. Bone Mineral Density in Prostate Cancer: A Comparative Study of Patients With Prostate Cancer and Healthy Controls Using Propensity Score Matching. Urology. 2014 Feb;83(2):385 92. 28. You D, Jeong IG, Song C, Cho YM, Hong JH, Kim CS, Ahn H. High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage?t3a prostate cancer with a negative surgical margin. Int J Urol. 2014 May;21(5):484 9. 27. Kim Y, Jeong IG, You D, Song SH, Suh N, Jang SW, Kim S, Hwang JJ, Kim CS. Sodium meta arsenite induces reactive oxygen species dependent apoptosis, necrosis, and autophagy in both androgen sensitive and androgen insensitive prostate cancer cells. Anticancer Drugs. 2014 Jan;25(1):53 62. 26. Jeong IG, You D, Yoon JH, Hong S, Lim JH, Hong JH, Choo MS, Ahn H, Kim CS. Impact of tamsulosin on urinary retention following early catheter removal after robot assisted laparoscopic radical prostatectomy: A prospective randomized controlled trial. Int J Urol. 2014 Feb;21(2):164 8. 25. Jeong IG, Lim JH, You D, Kim MH, Choi HJ, Kim JK, Cho KS, Hong JH, Ahn H, Kim CS. Incremental Value of MRI in Clinically High risk Prostate Cancer: A Large Single institution Experience of 922 Radical Prostatectomy. J Urol. 2013 Dec;190(6):2054 60. 24. Hong S, Jeong IG, You D, Lee JL, Hong JH, Ahn H, Kim CS. Safety of megestrol acetate in palliating anorexia cachexia syndrome in patients with castration resistant prostate cancer. J Korean Med Sci. 2013 May;28(5):687 92. 23. Lim JH, You D, Jeong IG, Park HK, Ahn H, Kim CS. Cystoscopic injection of N butyl 2 cyanoacrylate followed by fibrin glue for the treatment of persistent or massive vesicourethral anastomotic urine leak after radical prostatectomy. Int J Urol. 2013 Oct;20(10):980 5. 22. You D, Jang MJ, Lee J, Jeong IG, Kim HS, Moon KH, Suh N, Kim CS. Periprostatic Implantation of Human Bone Marrow derived Mesenchymal Stem Cells Potentiates Recovery of Erectile Function by Intracavernosal Injection in a Rat Model of Cavernous Nerve Injury. Urology. 2013 Jan;81(1):104 10. 21. Lee C, Kim KH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS. Smoking and Survival After Radical Cystectomy for Bladder Cancer. Urology. 2012 Dec;80(6):1307 12. 20. Song HY, Kim CS, Jeong IG, Yoo D, Kim JH, Nam DH, Bae JI, Park JH. Placement of retrievable self expandable metallic stents with barbs into patients with obstructive prostate cancer. Eur Radiol. 2013 Mar;23(3):780 5. 19. Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus. BJU Int. 2012 Dec;110(11 Pt B):E673 8.

18. You D, Hong S, Lee C, Kim KS. Feasibility and Safety of Laparoscopic Ablative Renal Surgery in Infants: Comparative Study with Children. J Urol. 2012 Oct;188(4):1330 5. 17. You D, Jang MJ, Lee J, Suh N, Jeong IG, Sohn DW, Kim SW, Ahn TY, Kim CS. Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Prostate. 2013 Feb 15;73(3):278 86. 16. Kim CS, You D, Jeong IG. Can robotic surgery be a standard procedure in the treatment of prostate cancer? J Korean Med Assoc. 2012 Jul;55(7):629 34. 15. Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Muscle invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2012 May 14. [Epub ahead of print] 14. Kim KH, You D, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma. J Cancer Res Clin. 2012 Sep;138(9):1561 7. 13. Jeong IG, You D, Kim J, Kim SC, Hong JH, Ahn H, Kim CS. Does Factors associated with non orthotopic urinary diversion after radical cystectomy. World J Urol. 2012 Dec;30(6):815 20. 12. Park M, You D, Yoon JH, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? analysis by the number of cores taken at initial biopsy. BJU Int. 2012 May;109(10):1474 9. 11. You D, Shim M, Jeong IG, Kim JK, Ro JY, Hong JH, Ahn H, Kim CS. The multilocular cystic renal cell carcinoma: clinico pathologic features and preoperative prediction using multiphase computerized tomography. BJU Int. 2011 Nov;108(9):1444 9. 10. Jeong IG, You D, Kim JW, Song C, Hong JH, Ahn H, Kim CS. Outcomes of single lymph node positive urothelial carcinoma after radical cystectomy. J Urol. 2011 Jun;185(6):2085 90. 9. You D, Jeong IG, Ahn JH, Lee DH, Lee JL, Hong JH, Ahn H, Kim CS. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy. J Urol. 2011 Jan;185(1):54 9. 8. Jeong IG, Ro JY, Kim SC, You D, Song C, Hong JH, Ahn H, Kim CS. Extranodal extension in node positive bladder cancer: the continuing controversy. BJU Int. 2011 Jul;108(1):38 43. 7. Jeong IG, Kim JK, Cho KS, You D, Song C, Hong JH, Ahn H, Kim CS. Diffusion Weighted Magnetic Resonance Imaging in Patients With Unilateral Prostate Cancer on Extended Prostate Biopsy: Predictive Accuracy of Laterality and Implications for Hemi Ablative Therapy. J Urol. 2010 Nov;184(5):1963 9. 6. You D, Jeong IG, Kim SW, Chung BH, Cho JS, Lee HM, Yun SC, Kim CS. Impacts of leuprolide acetate on quality of life in patients with prostate cancer: A prospective multicenter study. Scand J Urol Nephrol. 2010 Dec;44(6):399 405. 5. You D, Kim SC, Jeong IG, Hong JH, Ro JY, Ahn H, Kim CS. Urothelial carcinoma of the bladder with seminal vesicle invasion: prognostic significance. BJU Int. 2010 Dec;106(11):1657 61. 4. You D, Park J, Hong B, Park HK. Effect of output voltage distribution on stone comminution efficiency during shockwave lithotripsy in renal or ureteropelvic junction stones: A preliminary study. Scand J Urol Nephrol. 2010 Sep;44(4):236 41. 3. Kwon T, Jeong IG, You D, Park MC, Hong JH, Ahn H, Kim CS. Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level? BJU Int. 2010 Sep;106(5):633 8. 2. You D, Bang JK, Shim M, Ryu DS, Kim KS. Analysis of the late outcome of laparoscopic heminephrectomy in children with duplex kidneys. BJU Int. 2010 Jul;106(2):250 4. 1. Song SH, Lee SB, Yoo DS, Kim KS. Fluoroscopy assisted retroperitoneal laparoscopic renal surgery in children. J Endourol. 2006 Apr;20(4):256 9.

OTHERS 25. Kwon T, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Prevalence and clinical significance of incidental (18)F fluoro 2 deoxyglucose uptake in prostate. Korean J Urol. 2015 Apr;56(4):288 94. 24. Lim B, You D, Jeong IG, Kwon T, Hong S, Song C, Cho YM, Hong B, Hong JH, Ahn H, Kim CS. Clinicopathological features of Xp11.2 translocation renal cell carcinoma. Korean J Urol. 2015 Mar;56(3):212 7. 23. Sohn M, Kwon T, Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS. Histologic variability and diverse oncologic outcomes of prostate sarcomas. Korean J Urol. 2014 Dec;55(12):797 801. 22. Kyung YS, You D, Kwon T, Song SH, Jeong IG, Song C, Hong B, Hong JH, Ahn H, Kim CS. The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses. Korean J Urol. 2014 Jul;55(7):446 52. 21. Lim JH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Prognosis of prostate cancer with other primary malignancies. Korean J Urol. 2014 May;55(5):327 34. 20. Pak S, Park S, Ryu J, Hong S, Song SH, You D, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol. 2013 Dec;54(12):824 9. 19. Ryu J, Kwon T, Kyung YS, Hong S, You D, Jeong IG, Kim CS. Retropubic Versus Robot Assisted Laparoscopic Prostatectomy for Prostate Cancer: A Comparative Study of Postoperative Complications. Korean J Urol. 2013 Nov;54(11):756 61. 18. Song G, Lee C, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Prostate specific antigen response rate of sequential chemotherapy in castration resistant prostate cancer: the results of real life practice. Prostate Int. 2013;1(3):125 32. 17. Jeong IG, Lim JH, Hwang SS, Kim SC, You D, Hong JH, Ahn H, Kim CS. Nomogram using transrectal ultrasound derived information predicting the detection of high grade prostate cancer on initial biopsy. Prostate Int. 2013;1(2):69 75. 16. You D, Hong JH. Rare Cause of Hydronephrosis. Korean J Urol. 2013 Mar 054(03): 204 6. 15. Choi D, Kim D, Kyung YS, Lim JH, Song SH, You D, Jeong IG, Kim CS. Clinical experience with limited lymph node dissection for prostate cancer in Korea: single center comparison of 247 open and 354 robot assisted laparoscopic radical prostatectomy series. Korean J Urol. 2012 Nov;53(11):755 60. 14. Kim D, Choi D, Lim JH, Yoon JH, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Changes in Prostate Cancer Aggressiveness over a 12 Year Period in Korea. Korean J Urol. 2012 Oct;53(10):680 5. 13. You D, Kim CS. Stem Cell Therapy for Erectile Dysfunction Following Radical Prostatectomy: From Bench to Bed. Journal of the Association of Stem Cell and Tissue Regeneration. 2011 Dec;1(1):1 10. 12. Lee C, You D, Park J, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index. Korean J Urol. 2011 Aug;52(8):524 30. 11. Yoo S, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle Invasive Bladder Cancer? Korean J Urol. 2011 Jul;52(7):446 51. 10. You D, Jeong IG, Kim CS. Role of radical prostatectomy for high risk prostate cancer. Korean J Urol. 2010 Sep;51(9):589 95. Epub 2010 Sep 16.11. Hong S, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Analysis of the Clinical Features of Patients with Metastatic Spinal Cord Compression Caused by Prostate Cancer. Korean J Urol 2009 Dec;50(12):1174 81. 9. You D, Shim M, Kim SC, Ha SH, Kwon T, Kim KS. Transperitoneal Laparoscopic Upper Pole Heminephrectomy in Pediatric Patients with Duplex Kidneys: Comparison with an Age Matched Cohort of Open Surgery. Korean J Urol 2009 Sep;50(9):879 83. 8. You D, Bang JK, Kim KS. Analysis of the Learning Curve for Laparoscopic Renal Surgeries in Children. Korean J Urol 2009 Apr;50(4): 380 5. 7. You D, Kim KS. Selection of Approach Method during Laparoscopic Renal Surgeries in Pediatric Patients. Korean J Urol 2007 Mar;48(3):276 82. 6. Song SH, Hong B, You D, Ahn TY. Vardenafil Improves Lower Urinary Tract Symptoms in Patients of Erectile Dysfunction. Kor J Androl 2006;24:13 7. 4. You D, Park T, Park HK. Endourologic Management for Calyceal Diverticular Stone. Korean J Urol 2005 Feb;46(2):144 8. 3. Song C, Kang T, You D, Hong JH, Ahn H. Expression of Bcl 2 and Bax in cis Diamminedichloroplatinum (II) Resistant Bladder Cancer Cell Lines. Korean J Urol 2004 May;45(5):472 7.

2. You D, Hong B, Park JY, Ahn TY. Risk Factors for Development of Long term Complications after Surgical Repair of Penile Fracture.KorJAndrol.2004;22:14 8. 1. Song SH, Ji YH, Lee SB, You D, Kim JK, Park JY, Ahn H, Kim CS. A Prospective Randomized Study Comparing Effectiveness of Local Anesthesia Techniques in Patients undergoing Transrectal Ultrasound guided Prostate Biopsy. Korean J Urol 2004 Mar;45(3):236 9.